XPH

SPDR S&P Pharmaceuticals ETF

Up$39.12
+$0.47
(+1.22%)
As of 3:11:11 PM EDT | 11/19/19  |  Market Open

XPH Trading Data

Open

$38.79

Low Price

$38.57

High Price

$39.14

Previous Last Price

$38.65

Bid Size

$39.09 X 3100

Ask Size

$39.12 X 1300

XPH Portfolio Data

AUM

$184,260,300

Shares

4,750

PE Ratio

10.33

Price / Book Ratio

2.68

Expense Ratio

0.35

Net Asset Value

$38.79

Volume

Volume

63,778

Avg. Volume (YDT)

66,176

Dollar Volume

$2,387,832

Weekly Avg. Volume

62,574

Monthly Avg. Volume

59,858

Quarterly Avg. Volume

86,493

XPH Fund Description

The SPDR SP Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Pharmaceuticals Select Industry Index.

XPH Chart

XPH Summary

Fund Family

State Street Global Advisors

Tracks This Index

SPDR S&P Pharmaceuticals ETF

Inception Date

2006-06-19

Asset Class

Equity

Asset Class Size

Biotech

XPH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

XPH Holdings

Top 10 Holdings

Reata Pharmaceuticals Inc. Class A (RETA)
5.53%
Bristol-Myers Squibb Company (BMY)
5.13%
Horizon Therapeutics Public Limited Company (HZNP)
4.97%
Allergan plc (AGN)
4.78%
Jazz Pharmaceuticals Plc (JAZZ)
4.57%
Johnson & Johnson (JNJ)
4.47%
Merck & Co. Inc. (MRK)
4.45%
Eli Lilly and Company (LLY)
4.42%
Pfizer Inc. (PFE)
4.37%
Catalent Inc (CTLT)
4.25%

Total XPH Holdings

Total Holdings: 42

Reata Pharmaceuticals Inc. Class A (RETA)
5.53%
Bristol-Myers Squibb Company (BMY)
5.13%
Horizon Therapeutics Public Limited Company (HZNP)
4.97%
Allergan plc (AGN)
4.78%
Jazz Pharmaceuticals Plc (JAZZ)
4.57%
Johnson & Johnson (JNJ)
4.47%
Merck & Co. Inc. (MRK)
4.45%
Eli Lilly and Company (LLY)
4.42%
Pfizer Inc. (PFE)
4.37%
Catalent Inc (CTLT)
4.25%
Nektar Therapeutics (NKTR)
4.23%
Zoetis Inc. Class A (ZTS)
4.22%
Elanco Animal Health Inc. (ELAN)
3.94%
Perrigo Co. Plc (PRGO)
3.82%
Mylan N.V. (MYL)
3.53%
Pacira Biosciences Inc. (PCRX)
3.2%
Endo International Plc (ENDP)
3.14%
Axsome Therapeutics Inc. (AXSM)
3.04%
Zogenix Inc. (ZGNX)
2.86%
Aerie Pharmaceuticals Inc. (AERI)
2.2%
MyoKardia Inc. (MYOK)
1.85%
Prestige Consumer Healthcare Inc (PBH)
1.76%
Cara Therapeutics Inc (CARA)
1.68%
Supernus Pharmaceuticals Inc. (SUPN)
1.49%
ANI Pharmaceuticals Inc. (ANIP)
1.14%
Innoviva Inc. (INVA)
1.05%
Corcept Therapeutics Incorporated. (CORT)
1.04%
Intersect ENT Inc (XENT)
0.98%
Tricida Inc (TCDA)
0.97%
Intra-Cellular Therapies Inc. (ITCI)
0.97%
Wave Life Sciences Ltd. (WVE)
0.9%
TherapeuticsMD Inc. (TXMD)
0.82%
Revance Therapeutics Inc. (RVNC)
0.78%
Collegium Pharmaceutical Inc. (COLL)
0.65%
CymaBay Therapeutics Inc. (CBAY)
0.62%
Phibro Animal Health Corporation Class A (PAHC)
0.62%
Omeros Corporation (OMER)
0.58%
Theravance Biopharma Inc (TBPH)
0.49%
Amphastar Pharmaceuticals Inc (AMPH)
0.38%
STATE STREET INSTL US GOVERNME STIF USD (85749246)
0.1%
SPDR SPDR S & P Pharmaceuticals ETF (XPH)
0%
U.S. Dollar
0%

XPH Technicals

Alpha

-16.94

Beta

1.34

Leverage

Long

Standard Deviation

2.2

XPH Dividends

Dividend Date

2019-09-23

Latest Dividend

0.084

Annual Dividend

0.33

Annual Dividend Rate

0.33

Annual Dividend Yield

0.84

XPH Performance

YTD Return

6.84%

1 Year Return

-9.1%

3 Year Return

-4.99%

5 Year Return

-32.84%

10 Year Return

110.63%

XPH Related Articles

4 Hot Pharmaceutical ETFs

4 Hot Pharmaceutical ETFs

Pharmaceutical ETFs invest in stocks of companies that are involved in the research, development, manufacture, sale or distribution of pharmaceuticals…

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.